Company Filing History:
Years Active: 1998-2016
Title: Minzhen Xu: Innovating Cancer Vaccine Technologies
Introduction
Minzhen Xu, a prolific inventor located in Northborough, Massachusetts, holds an impressive portfolio of 13 patents. His pioneering work in biotechnology, particularly in the field of cancer immunotherapy, showcases his commitment to advancing medical science.
Latest Patents
Minzhen Xu's recent patents include groundbreaking innovations such as the II-key/antigenic epitope hybrid peptide vaccines. This invention involves an antigen presentation-enhancing hybrid polypeptide containing three critical elements: an N-terminal element derived from the mammalian li-Key peptide, a versatile chemical structure linking the N-terminal to the MHC Class II-presented epitope, and a C-terminal element that comprises an antigenic epitope binding to an MHC class II molecule. Another notable patent is the Ii-key/HER-2/neu hybrid cancer vaccine, which provides methods for treating cancers characterized by the expression of Her-2/neu. This vaccine stimulates an immune response to the native Her-2/neu protein, focusing on treating breast cancer patients and potentially offering significant therapeutic advantages.
Career Highlights
Throughout his career, Minzhen Xu has been associated with esteemed organizations such as Antigen Express, Inc. and the University of Massachusetts. His contributions to these institutions have enabled significant advancements in the field of health and immunotherapy, drawing attention to novel methods of vaccine development.
Collaborations
In his research endeavors, Minzhen Xu has collaborated with notable professionals, including Robert E Humphreys and Sharlene Adams. These partnerships have fostered an environment of innovation, allowing for the exchange of ideas and enhancing the development of new therapeutic methods.
Conclusion
Minzhen Xu continues to make remarkable strides in the field of vaccine technology, particularly in cancer treatment. His 13 patents serve as a testament to his creativity and determination in addressing significant medical challenges. With ongoing research and collaboration, Xu's work has the potential to save lives and improve patient outcomes in the fight against cancer.